Nasal drug delivery devices: characteristics and performance in a clinical perspective-a review

被引:370
作者
Djupesland, Per Gisle [1 ]
机构
[1] OptiNose, Oslo, Norway
关键词
Drug delivery; Nasal; Device; Paranasal sinuses; Topical; Systemic; Vaccine; Nasal valve; Particle deposition; Clearance;
D O I
10.1007/s13346-012-0108-9
中图分类号
TH7 [仪器、仪表];
学科分类号
0804 ; 080401 ; 081102 ;
摘要
Nasal delivery is the logical choice for topical treatment of local diseases in the nose and paranasal sinuses such as allergic and non-allergic rhinitis and sinusitis. The nose is also considered an attractive route for needle-free vaccination and for systemic drug delivery, especially when rapid absorption and effect are desired. In addition, nasal delivery may help address issues related to poor bioavailability, slow absorption, drug degradation, and adverse events in the gastrointestinal tract and avoids the first-pass metabolism in the liver. However, when considering nasal delivery devices and mechanisms, it is important to keep in mind that the prime purpose of the nasal airway is to protect the delicate lungs from hazardous exposures, not to serve as a delivery route for drugs and vaccines. The narrow nasal valve and the complex convoluted nasal geometry with its dynamic cyclic physiological changes provide efficient filtration and conditioning of the inspired air, enhance olfaction, and optimize gas exchange and fluid retention during exhalation. However, the potential hurdles these functional features impose on efficient nasal drug delivery are often ignored. With this background, the advantages and limitations of existing and emerging nasal delivery devices and dispersion technologies are reviewed with focus on their clinical performance. The role and limitations of the in vitro testing in the FDA guidance for nasal spray pumps and pressurized aerosols (pressurized metered-dose inhalers) with local action are discussed. Moreover, the predictive value and clinical utility of nasal cast studies and computer simulations of nasal airflow and deposition with computer fluid dynamics software are briefly discussed. New and emerging delivery technologies and devices with emphasis on Bi-Directional (TM) delivery, a novel concept for nasal delivery that can be adapted to a variety of dispersion technologies, are described in more depth.
引用
收藏
页码:42 / 62
页数:21
相关论文
共 117 条
  • [1] The assessment of topical nasal drug distribution
    Aggarwal, R
    Cardozo, A
    Homer, JJ
    [J]. CLINICAL OTOLARYNGOLOGY, 2004, 29 (03) : 201 - 205
  • [2] Gamma scintigraphy for testing bioequivalence: A case study on two cromolyn sodium nasal spray preparations
    Al-Ghananeem, Abeer M.
    Sandefer, Erik P.
    Doll, Walter J.
    Page, Richard C.
    Chang, Yunik
    Digenis, George A.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 357 (1-2) : 70 - 76
  • [3] HUMAN RESPONSE TO CONTROLLED LEVELS OF SULFUR-DIOXIDE
    ANDERSEN, I
    LUNDQVIS.GR
    JENSEN, PL
    PROCTOR, DF
    [J]. ARCHIVES OF ENVIRONMENTAL HEALTH, 1974, 28 (01): : 31 - 39
  • [4] Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity
    Bakke, H
    Samdal, HH
    Holst, J
    Oftung, F
    Haugen, IL
    Kristoffersen, AC
    Haugan, A
    Janakova, L
    Korsvold, GE
    Krogh, G
    Andersen, EAS
    Djupesland, P
    Holand, T
    Rappuoli, R
    Haneberg, B
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2006, 63 (03) : 223 - 231
  • [5] Neural regulation of mucosal function
    Baraniuk, James N.
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2008, 21 (03) : 442 - 448
  • [6] Live attenuated versus inactivated influenza vaccine in infants and young children
    Belshe, Robert B.
    Edwards, Kathryn M.
    Vesikari, Timo
    Black, Steven V.
    Walker, Robert E.
    Hultquist, Micki
    Kemble, George
    Connor, Edward M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07) : 685 - 696
  • [7] Techniques of intranasal steroid use
    Benninger, MS
    Hadley, JA
    Osguthorpe, JD
    Marple, BF
    Leopold, DA
    Derebery, MJ
    Hannley, M
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2004, 130 (01) : 5 - 24
  • [8] Intranasal corticosteroids: the development of a drug delivery device for fluticasone furoate as a potential step toward improved compliance
    Berger, William E.
    Godfrey, James W.
    Slater, Anna L.
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2007, 4 (06) : 689 - 701
  • [9] Bond W, 1985, P BIOPH, VI, P93
  • [10] Within reach of an end to unnecessary bitterness?
    Brand, JG
    [J]. LANCET, 2000, 356 (9239) : 1371 - 1372